Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Normal Pressure Hydrocephalus Treatment by Acetazolamide [Phase 3]

View source ↗

Summary

Phase 3 trial of acetazolamide for normal pressure hydrocephalus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Rabin Medical Center | Conditions: Motor Condition as Measured by Quantified Scale, Cognitive Investigation | Phase 3 | Status: TERMINATED